RESMED INC — Director's Dealing 2022

Nov 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2022-10-31

Reporting Person: FARRELL PETER C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-31	ResMed Common Stock	S	9050	$221.9754	Disposed	183052	Direct
2022-10-31	ResMed Common Stock	G	4550	—	Disposed	178502	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $217.65 to $224.11. The price reported above reflects the weighted average sale price.

F2: Represents a gift of shares to Bank of America, N.A. Successor Trustee of Peter C. Farrell Charitable Remainder Unitrust. Dr. Farrell has no beneficial interest, control or dispositive power over the gifted shares.